≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Exclusion endpoint for clefts

Endpoint Browser

Q17_CLEFT_PALATE_EXCLUDE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

3 out of 7 registries used, show all original rules.

763

4. Check minimum number of events

None

763

5. Include endpoints

None

763

6. Filter based on genotype QC (FinnGen only)

763

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 763 413 350
Unadjusted period prevalence (%) 0.15 0.14 0.15
Median age at first event (years) 24.63 26.09 22.90

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
697
Matched controls
6962
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q87.4
ICD-10 Finland
Marfan syndrome
+∞
207.9
189
*
Z31.5
ICD-10 Finland
Genetic counselling
17.7
158.8
268
237
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
120.3
112
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
6.7
68.9
199
394
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
28.7
61.6
84
33
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.6
52.8
219
634
ZXD10
NOMESCO Finland
Scheduled procedure
3.4
48.8
361
1686
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
48.8
303
1237
Q87.09
ICD-10 Finland
Other congenital malformations that mainly affect the appearance of the face
+∞
48.5
46
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.4
47.5
332
1477
Z2221
NOMESCO Finland
Medical doctor
3.4
46.5
301
1257
Q87.80
ICD-10 Finland
Alport syndrome
+∞
45.3
43
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.7
44.6
171
448
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.8
40.3
205
692
XF400
NOMESCO Finland
ECG with 12 standard connections
3.8
39.6
197
651
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
10.7
39.3
78
81
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
39.5
38.3
48
13
Q87.14
ICD-10 Finland
Noonan's syndrome
+∞
37.8
36
*
R4110
NOMESCO Finland
Physiotherapy
3.1
36.9
257
1090
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
5.3
36.5
120
262
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.1
34.9
152
441
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.2
34.1
113
248
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
33.8
306
1518
Q86.0
ICD-10 Finland
Fetal alcohol syndrome (dysmorphic)
+∞
33.6
32
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
8.6
33.0
74
95
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
6.6
32.8
89
152
Q87.21
ICD-10 Finland
Klippel-Trénaunay-Weber syndrome
+∞
32.5
31
*
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
45.7
32.1
39
9
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.5
31.9
172
594
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
31.9
228
967
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
23.9
31.7
45
20
F83
ICD-10 Finland
Mixed specific developmental disorders
7.9
30.6
72
100
ZXA10
NOMESCO Finland
Bilateral
3.3
30.2
176
641
ZXE00
NOMESCO Finland
One hour or less
2.6
29.9
344
1922
Z3229
NOMESCO Finland
Other healthcare associate professional
4.3
29.0
116
307
PD5BD
NOMESCO Finland
Extensive CT of aorta
22.2
29.0
42
20
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.0
28.3
97
219
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.1
27.2
115
320
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
18.8
26.9
41
23
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
+∞
26.2
25
*
H01AC01
ATC
somatropin; parenteral
8.8
26.1
57
70
Z3226
NOMESCO Finland
Physiotherapist
2.8
25.3
203
901
B01AA03
ATC
warfarin; systemic
3.9
25.3
114
335
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
+∞
25.1
24
*
R62.0
ICD-10 Finland
Delayed milestone
6.4
24.9
67
113
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.3
24.1
76
156
FCA60
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis
69.9
24.0
27
*
I71.09
ICD-10 Finland
Aortic dissection [regardless of location]
89.9
23.8
26
*
ZXD05
NOMESCO Finland
Urgent procedure
2.4
23.6
254
1323
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
12.7
23.6
42
35
ZXA00
NOMESCO Finland
Right side
2.7
22.9
183
804
H27.1
ICD-10 Finland
Dislocation of lens
86.3
22.8
25
*
I34.1
ICD-10 Finland
Mitral (valve) prolapse
12.4
22.8
41
35
WX002
NOMESCO Finland
Sedation and analgesia
3.1
22.1
137
512
Z3231
NOMESCO Finland
Registered nurse
2.4
22.1
260
1405
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
22.0
173
752
H52.2
ICD-10 Finland
Astigmatism
7.0
21.9
55
84
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
26.0
21.9
30
12
Z2446
NOMESCO Finland
Social worker
3.2
21.8
129
464
H52.1
ICD-10 Finland
Myopia
5.2
21.7
70
147
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
21.4
101
307
ZXE40
NOMESCO Finland
More than seven and less than nine hours
7.7
21.3
50
69
XF404
NOMESCO Finland
Ambulatory ECG
4.1
21.1
86
230
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
20.7
149
612
I71.00
ICD-10 Finland
Dissecting aneurysm of aorta (ruptured) [any part]
59.3
20.0
23
*
Q87.8
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
19.9
19
*
I71.01
ICD-10 Finland
Aneurysm of the descending aorta
205.3
19.6
20
*
C07AB07
ATC
bisoprolol; oral
2.3
19.5
217
1129
C03CA01
ATC
furosemide; systemic
3.0
19.3
121
452
101
Kela drug reimbursment
Anterior pituitary hypofunction
8.8
19.2
41
49
WX872
NOMESCO Finland
Intensive care
6.6
19.1
50
81
ZXA05
NOMESCO Finland
Left side
2.6
19.0
162
731
Q87.16
ICD-10 Finland
Mulibrey nanism
+∞
18.8
18
*
F82
ICD-10 Finland
Specific developmental disorder of motor function
8.2
18.8
42
54
P85
ICPC
Mental retardation
13.4
18.1
31
24
B01AB05
ATC
enoxaparin; parenteral
2.5
18.0
162
748
7598B
ICD-9 Finland
Other and unspecified congenital anomalies, Other specified anomalies[SYNDROMA MARFAN]
+∞
17.8
17
*
Q87.30
ICD-10 Finland
Syndrome Beckwith-Wiedemann
+∞
17.8
17
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.5
17.6
86
268
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
17.6
177
866
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.0
17.3
43
65
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.7
17.2
78
228
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.1
17.1
68
177
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.1
17.1
68
177
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
17.1
148
671
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.3
17.1
92
309
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
64.9
16.8
19
*
DFF00
NOMESCO Finland
Pure tone audiometry
3.7
16.7
75
218
Q35.1
ICD-10 Finland
Cleft hard palate
92.2
16.6
18
*
RL140
NOMESCO Finland
NA
9.1
16.3
34
39
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.7
16.3
47
87
301
Kela drug reimbursment
Growth hormone
13.2
16.3
28
22
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
3.1
15.9
90
313
Q35.71
ICD-10 Finland
Submucous cleft palate
+∞
15.7
15
*
R4130
NOMESCO Finland
Speech therapy
5.9
15.7
44
79
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
15.6
169
851
WX402
NOMESCO Finland
General anaesthesia
2.3
15.5
163
811
75988
ICD-8 Finland
Congenital syndromes affecting multiple systems, Aliae definitae
163.3
15.5
16
*
TFP20
NOMESCO Finland
Cardiodefibrillation
5.3
15.3
47
94
H65.3
ICD-10 Finland
Chronic mucoid otitis media
3.4
15.0
74
232
TJD20
NOMESCO Finland
Change of gastrostomy tube
12.8
15.0
26
21
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
16.9
14.8
23
14
Q25.0
ICD-10 Finland
Patent ductus arteriosus
10.7
14.8
28
27
FM2CE
NOMESCO Finland
NA
4.3
14.8
56
140
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.3
14.7
77
253
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
14.7
106
430
XA800
NOMESCO Finland
Neuropsychological investigation
3.4
14.6
73
231
Q87.10
ICD-10 Finland
Aarskog syndrome
+∞
14.6
14
*
Q87.04
ICD-10 Finland
Syndrome Robin
+∞
14.6
14
*
Q38.60
ICD-10 Finland
Fordyce disease
+∞
14.6
14
*
C01AA05
ATC
digoxin; systemic
6.0
14.6
40
70
AJ1
HP
Reconstruction of the aortic base, eg composite graft, incl. valve saving operation
152.9
14.5
15
*
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
152.9
14.5
15
*
WX892
NOMESCO Finland
Monitored bed care
3.3
14.3
75
247
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
7.9
14.3
32
42
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
7.9
14.3
32
42
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
14.2
96
372
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
14.8
14.1
23
16
XFE00
NOMESCO Finland
Epicardial ultrasonography
8.6
14.1
30
36
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
7.1
14.1
34
50
201
Kela drug reimbursment
Chronic cardiac insufficiency
5.4
14.0
42
82
G91.0
ICD-10 Finland
Communicating hydrocephalus
30.7
13.9
18
6
H50.0
ICD-10 Finland
Convergent concomitant strabismus
9.4
13.8
28
31
SPAT1229
SPAT
Assessment of need for aid
4.7
13.8
47
106
Q87.0
ICD-10 Finland
Congenital malformation syndromes predominantly affecting facial appearance
+∞
13.6
13
*
ENC80
NOMESCO Finland
Plastic operation of soft palate for voice distubance
+∞
13.6
13
*
Q87.26
ICD-10 Finland
VATER association
+∞
13.6
13
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
7.5
13.4
31
43
H52.0
ICD-10 Finland
Hypermetropia
5.1
13.3
42
87
JDB10
NOMESCO Finland
Percutaneous gastrostomy
9.9
13.3
26
27
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
7.3
13.2
31
44
A12AA04
ATC
calcium carbonate; oral
7.9
13.0
29
38
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
11.8
12.9
23
20
Q21.10
ICD-10 Finland
Persistent ostium secundum
6.0
12.8
35
61
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
12.8
82
308
I50.9
ICD-10 Finland
Heart failure, unspecified
4.0
12.8
52
139
UDC00
NOMESCO Finland
Ear microscopy
2.9
12.7
79
292
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.9
12.7
53
145
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.5
12.7
37
70
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.4
12.7
33
54
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
12.7
316
2180
UGC02
NOMESCO Finland
Rigid bronchoscopy
10.3
12.6
24
24
PD5CM
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet
+∞
12.5
12
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.3
12.2
32
53
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.8
12.2
81
310
L28
ICPC
Limited function/disability (L)
2.8
12.1
79
301
R31
ICD-10 Finland
Unspecified haematuria
3.8
12.1
52
146
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
12.1
141
729
Q82.50
ICD-10 Finland
Naevus flammeus
27.2
12.1
16
6
R4120
NOMESCO Finland
Occupational therapy
3.2
12.0
64
213
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
12.0
44
107
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
10.8
11.8
22
21
RS220
NOMESCO Finland
NA
6.2
11.8
31
52
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
16.7
11.7
18
11
K83
ICPC
Heart valve disease NOS
30.6
11.7
15
5
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
11.3
11.6
21
19
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.8
11.5
38
83
7597A
ICD-9 Finland
Other and unspecified congenital anomalies, Multiple congenital anomalies, so described
+∞
11.5
11
*
Q87.15
ICD-10 Finland
Prader-Willi syndrome
+∞
11.5
11
*
Q87.28
ICD-10 Finland
Congenital malformation syndromes predominantly involving limbs
+∞
11.5
11
*
Q87.5
ICD-10 Finland
Other congenital malformation syndromes with other skeletal changes
+∞
11.5
11
*
D82.1
ICD-10 Finland
Di George syndrome
+∞
11.5
11
*
Q87.84
ICD-10 Finland
Williams syndrome
+∞
11.5
11
*
Q87.03
ICD-10 Finland
Syndrome Goldenhar
+∞
11.5
11
*
Q87.1
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
+∞
11.5
11
*
ZXD20
NOMESCO Finland
Day surgery
2.4
11.4
103
469
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.3
11.4
57
182
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
11.3
54
166
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
9.8
11.3
22
23
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.2
11.3
59
194
H53.0
ICD-10 Finland
Amblyopia ex anopsia
5.6
11.3
32
59
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
4.8
11.2
37
81
R1260
NOMESCO Finland
Evaluation of communicative skills
7.0
11.2
27
40
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
11.1
48
136
XF600
NOMESCO Finland
Bloodpressure measurement
2.7
11.1
77
306
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
6.6
10.9
27
42
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
9.8
10.8
21
22
Q21.30
ICD-10 Finland
Tetralogy of Fallot
28.5
10.7
14
5
K84
ICPC
Heart disease other
7.7
10.7
24
32
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
13.1
10.7
18
14
H50.31
ICD-10 Finland
Intermittent exotropia
5.9
10.7
29
51
GD1AD
NOMESCO Finland
Thorax CT examination
4.5
10.6
37
86
A11CC03
ATC
alfacalcidol; systemic
5.2
10.6
32
64
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
10.6
206
1290
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
9.4
10.6
21
23
RS222
NOMESCO Finland
NA
5.8
10.5
29
52
Q91.0
ICD-10 Finland
Trisomy 18, meiotic nondisjunction
+∞
10.4
10
*
FCD60
NOMESCO Finland
Resection of thoracoabdominal aorta and reimplantation of branches
+∞
10.4
10
*
Q87.31
ICD-10 Finland
Syndrome Sotos
+∞
10.4
10
*
Q87.38
ICD-10 Finland
Syndrome Weaver
+∞
10.4
10
*
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
+∞
10.4
10
*
75980
ICD-8 Finland
Congenital syndromes affecting multiple systems, Syndroma Marfan, arachnodactylia
+∞
10.4
10
*
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
4.4
10.4
37
88
CG2T4
NOMESCO Finland
Topography assessment of cornea
16.3
10.4
16
10
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
16.3
10.4
16
10
Q27.4
ICD-10 Finland
Congenital phlebectasia
33.0
10.3
13
*
WX882
NOMESCO Finland
High dependency care
3.0
10.3
59
206
EB1WA
NOMESCO Finland
NA
10.8
10.3
19
18
N02AX02
ATC
tramadol; systemic, rectal
1.8
10.2
203
1278
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
10.2
112
563
ZX120
NOMESCO Finland
Intravenous
2.7
10.1
73
293
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
10.0
54
182
K03.66
ICD-10 Finland
Tooth plaque
2.4
10.0
88
397
C09CA01
ATC
losartan; oral
2.2
10.0
104
509
I71.1
ICD-10 Finland
Thoracic aortic aneurysm, ruptured
40.6
10.0
12
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
6.1
9.9
26
44
61
HP
Catheterization and pressure measurement of the left side of the heart
12.4
9.9
17
14
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.7
9.9
42
118
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
8.9
9.8
20
23
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.9
9.8
61
226
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
9.7
130
706
C07AB03
ATC
atenolol; systemic
4.7
9.7
32
71
FCA75
NOMESCO Finland
Valve-sparing repair of aortic root (David, Yacoub)
55.7
9.7
11
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
6.1
9.6
25
42
4122
FHL
Tympanostomy (tympanic tube)
4.3
9.5
34
82
XF640
NOMESCO Finland
NA
6.3
9.4
24
39
Z96.1
ICD-10 Finland
Presence of intraocular lens
3.4
9.4
45
139
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
17.8
9.4
14
8
Q79.8
ICD-10 Finland
Other congenital malformations of musculoskeletal system
+∞
9.4
9
*
FCC50
NOMESCO Finland
Resection and reconstruction of descending aorta using tube graft
+∞
9.4
9
*
7598X
ICD-9 Finland
Other and unspecified congenital anomalies, Other specified anomalies[ANOMALIAE CONGENITAE ALIAE DEFINITAE]
+∞
9.4
9
*
Q87.82
ICD-10 Finland
Zellweger syndrome
+∞
9.4
9
*
Q87.22
ICD-10 Finland
Nail-patella syndrome
+∞
9.4
9
*
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
22.0
9.4
13
6
R50.9
ICD-10 Finland
Fever, unspecified
2.0
9.4
129
709
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.6
9.3
23
36
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
9.3
167
1014
R5120
NOMESCO Finland
Preparation of an aid
6.8
9.2
22
33
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.6
9.1
65
262
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
37.2
9.0
11
*
N03AF02
ATC
oxcarbazepine; oral
3.8
8.9
37
102
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
8.9
64
259
PD5BG
NOMESCO Finland
MRI examination of thoracal and abdominal aortta with high intensity magnet
24.3
8.9
12
5
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
8.9
61
241
DFF20
NOMESCO Finland
Audiometry for children
5.2
8.8
26
51
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.5
8.8
25
47
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
6.1
8.8
23
39
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
4.1
8.7
33
84
KFH10
NOMESCO Finland
Orchiopexy
14.2
8.7
14
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
8.7
245
1702
F79
ICD-10 Finland
Unspecified mental retardation
50.6
8.7
10
*
Z94.0
ICD-10 Finland
Kidney transplant status
5.6
8.7
24
44
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
11.7
8.6
15
13
EEC05
NOMESCO Finland
Le Fort I osteotomy
16.5
8.6
13
8
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
9.1
8.6
17
19
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.2
8.6
31
76
AA1AD
NOMESCO Finland
CT of head and brain
2.0
8.5
108
572
Z2445
NOMESCO Finland
Psychologist
2.3
8.5
76
346
127
Kela drug reimbursment
Transplant complication
4.5
8.5
29
67
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
8.5
45
151
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
8.5
64
266
62
HP
Catheterization and pressure measurement of the right side of the heart
20.3
8.5
12
6
Q66.0
ICD-10 Finland
Talipes equinovarus
20.3
8.5
12
6
XF402
NOMESCO Finland
ECG with work load test
2.6
8.5
61
248
Q67.0
ICD-10 Finland
Facial asymmetry
91.0
8.4
9
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
12.9
8.4
14
11
RT150
NOMESCO Finland
NA
5.4
8.4
24
46
Q87.27
ICD-10 Finland
CHARGE association
+∞
8.3
8
*
C07AB02
ATC
metoprolol; systemic
2.3
8.3
77
357
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.9
8.2
32
84
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.3
8.2
78
363
C03DA01
ATC
spironolactone; oral
2.8
8.2
52
196
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
5.8
8.2
22
39
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
4.0
8.1
31
80
Q76.30
ICD-10 Finland
Hemivertebra fusion or failure of segmentation with scoliosis
33.7
8.1
10
*
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
33.7
8.1
10
*
TK800
NOMESCO Finland
Hemodialysis
5.1
8.1
24
48
PD5AD
NOMESCO Finland
CT of aorta
10.2
8.1
15
15
RT160
NOMESCO Finland
NA
6.4
8.0
20
32
XKC03
NOMESCO Finland
Water cystometry
5.4
8.0
23
44
Q23.10
ICD-10 Finland
Congenital insufficiency of aortic valve
22.3
8.0
11
5
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
8.0
121
687
H65.2
ICD-10 Finland
Chronic serous otitis media
5.0
7.9
24
49
WX110
NOMESCO Finland
Local anesthesy
1.6
7.9
479
4013
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
6.7
7.9
19
29
Z50.5
ICD-10 Finland
Speech therapy
3.1
7.9
42
142
WX140
NOMESCO Finland
Parabulbar anesthesy
5.5
7.9
22
41
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.4
7.9
37
114
SPAT1262
SPAT
Handing over of treatment supplies
2.1
7.9
94
488
H66.9
ICD-10 Finland
Otitis media, unspecified
2.0
7.9
105
567
RD210
NOMESCO Finland
NA
3.0
7.9
43
148
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.1
7.8
29
73
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.9
7.8
31
83
31
HP
Congenital heart failure surgery
15.2
7.7
12
8
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
7.7
78
377
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
45.4
7.7
9
*
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
45.4
7.7
9
*
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
45.4
7.7
9
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
5.7
7.7
21
38
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
7.7
50
192
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
7.7
44
155
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
7.7
52
203
C07AA07
ATC
sotalol; systemic
5.0
7.6
23
47
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
7.6
144
880
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.7
7.6
50
194
M41.5
ICD-10 Finland
Other secondary scoliosis
25.3
7.6
10
*
PD5DG
NOMESCO Finland
Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
25.3
7.6
10
*
A06AD11
ATC
lactulose; oral
2.5
7.6
61
262
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
10.2
7.5
14
14
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
7.5
55
225
A28
ICPC
Limited function/disability NOS
2.5
7.5
59
253
4364
FHL
Pharyngeal tongue plastic
80.8
7.4
8
*
Z82.6
ICD-10 Finland
Family history of arthritis and other diseases of the musculoskeletal system and connective tissue
80.8
7.4
8
*
EHC30
NOMESCO Finland
Reconstruction of palate
80.8
7.4
8
*
H81
ICPC
Excessive ear wax
2.2
7.3
75
365
7844L
ICD-9 Finland
Symptoms involving head and neck, Voice disturbance[RINOPHONIA SEU RHINOLALIA]
+∞
7.3
7
*
Q91.2
ICD-10 Finland
Trisomy 18, translocation
+∞
7.3
7
*
Q38.80
ICD-10 Finland
Congenital nasopharyngeal dysmotility
+∞
7.3
7
*
26
HP
Aortic root """"composite graft""""
+∞
7.3
7
*
7834D
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]
+∞
7.3
7
*
RL130
NOMESCO Finland
NA
5.2
7.3
21
41
A03FA02
ATC
cisapride; oral, rectal
2.8
7.3
46
173
J01MA12
ATC
levofloxacin; systemic
2.1
7.2
85
437
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
7.2
89
467
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
7.4
7.2
16
22
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
4.5
7.2
24
55
EB1MA
NOMESCO Finland
Cephalometry with X-ray
2.3
7.2
65
299
PDG51
NOMESCO Finland
Bypass from aorta to iliac artery for aneurysm
30.3
7.2
9
*
FCA50
NOMESCO Finland
Resection and reconstruction of ascending aorta using tube graft
30.3
7.2
9
*
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
30.3
7.2
9
*
Q27.88
ICD-10 Finland
Other specified congenital malformation of peripheral vascular system
30.3
7.2
9
*
E34.30
ICD-10 Finland
Short stature NOS
8.0
7.1
15
19
H25.1
ICD-10 Finland
Senile nuclear cataract
2.4
7.1
59
260
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
7.1
172
1132
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
8.9
7.1
14
16
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
8.9
7.1
14
16
M21.7
ICD-10 Finland
Unequal limb length (acquired)
10.2
7.0
13
13
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
10.2
7.0
13
13
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
3.7
7.0
29
81
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.6
6.9
29
82
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.1
6.9
25
62
H26.2
ICD-10 Finland
Complicated cataract
7.6
6.9
15
20
UKC02
NOMESCO Finland
Cystoscopy
2.3
6.9
63
291
ZXC12
NOMESCO Finland
Pulse colorlaser
13.9
6.9
11
8
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.9
466
3935
205
Kela drug reimbursment
Chronic hypertension
2.1
6.9
82
423
SPAT1231
SPAT
Assessment of adjustments needed in living environment
8.4
6.8
14
17
L04AA01
ATC
[U] ciclosporin; systemic
6.8
6.8
16
24
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
6.8
319
2473
TQW40
NOMESCO Finland
Remowal of suture of skin
2.8
6.8
41
151
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
11.1
6.8
12
11
7505
FHL
Funicular lysis and orchidopexy
11.1
6.8
12
11
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
9.4
6.8
13
14
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
9.4
6.8
13
14
WZC30
NOMESCO Finland
Teaching
2.1
6.8
80
414
74900
ICD-8 Finland
Cleft palate and cleft lip, Cleft palate
40.4
6.8
8
*
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
40.4
6.8
8
*
AJ2
HP
Reconstruction of the ascending aorta
40.4
6.8
8
*
F70
ICD-10 Finland
Mild mental retardation
40.4
6.8
8
*
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
40.4
6.8
8
*
I37.1
ICD-10 Finland
Pulmonary valve insufficiency
40.4
6.8
8
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.5
6.8
53
225
O35.2
ICD-10 Finland
Maternal care for (suspected) hereditary disease in fetus
16.9
6.8
10
6
F80.1
ICD-10 Finland
Expressive language disorder
3.6
6.7
28
79
S18
ICPC
Laceration/cut
1.6
6.7
217
1539
RK110
NOMESCO Finland
NA
7.3
6.7
15
21
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.0
6.7
20
41
P94.2
ICD-10 Finland
Congenital hypotonia
22.7
6.7
9
*
602
Kela drug reimbursment
Children's severe malnutrition
3.5
6.7
29
85
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
5.2
6.7
19
37
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
5.6
6.6
18
33
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
7.9
6.6
14
18
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
2.9
6.6
38
135
M41.4
ICD-10 Finland
Neuromuscular scoliosis
12.4
6.6
11
9
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
12.4
6.6
11
9
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
12.4
6.6
11
9
SJC00
NOMESCO Finland
Bracket with fixed attachment
12.4
6.6
11
9
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
6.6
116
693
K07.24
ICD-10 Finland
Open bite
3.8
6.5
26
71
H50.30
ICD-10 Finland
Intermittent esotropy
5.1
6.5
19
38
K59.0
ICD-10 Finland
Constipation
2.9
6.5
38
137
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.5
6.5
49
205
N18.8
ICD-10 Finland
Other chronic renal failure
4.6
6.5
21
47
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
6.3
6.5
16
26
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.0
6.5
35
121
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
6.4
41
154
CJG40
NOMESCO Finland
Extraction of dislocated lens with implantation of artificial scleral fixed lens in posterior chamber and iridectomy or iridotomy
70.4
6.4
7
*
Q35.3
ICD-10 Finland
Cleft soft palate
70.4
6.4
7
*
I72.3
ICD-10 Finland
Aneurysm and dissection of iliac artery
70.4
6.4
7
*
Q35.9
ICD-10 Finland
Cleft palate, unspecified
70.4
6.4
7
*
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
70.4
6.4
7
*
Q14.8
ICD-10 Finland
Other congenital malformations of posterior segment of eye
70.4
6.4
7
*
GE1BE
NOMESCO Finland
Mediastinal ultrasound examinaiton through oesophagus
70.4
6.4
7
*
Q21.21
ICD-10 Finland
Atrioventricular duct
70.4
6.4
7
*
37870
ICD-8 Finland
Other diseases of eye, Subluxatio et luxatio lentis
70.4
6.4
7
*
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
14.4
6.4
10
7
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
14.4
6.4
10
7
NFK20
NOMESCO Finland
Epiphysiodesis of femur
14.4
6.4
10
7
N03AG01
ATC
valproic acid; systemic, rectal
2.5
6.4
49
208
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
6.4
124
762
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.5
6.4
21
48
J01MA02
ATC
ciprofloxacin; systemic
1.6
6.4
175
1189
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
2.2
6.4
64
309
H50.1
ICD-10 Finland
Divergent concomitant strabismus
6.6
6.4
15
23
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.2
6.3
22
53
H26.02
ICD-10 Finland
Presenil cataract
5.2
6.3
18
35
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
5.2
6.3
18
35
JAH00
NOMESCO Finland
Laparotomy
4.1
6.3
23
58
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.6
6.3
17
31
137
Kela drug reimbursment
Uraemia requiring dialysis
6.0
6.3
16
27
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
6.3
70
352
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
11.1
6.3
11
10
WX722
NOMESCO Finland
PEEP
3.0
6.3
33
112
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
18.2
6.3
9
5
Q16.1
ICD-10 Finland
Congenital absence, atresia and stricture of auditory canal (external)
18.2
6.3
9
5
Q87.23
ICD-10 Finland
Rubinstein-Taybi syndrome
+∞
6.3
6
*
Q27.0
ICD-10 Finland
Congenital absence and hypoplasia of umbilical artery
+∞
6.3
6
*
74642
ICD-8 Finland
Congenital anomalies of heart, Defectus septi atriorum, ostium secundum
+∞
6.3
6
*
Q91.1
ICD-10 Finland
Trisomy 18, mosaicism (mitotic nondisjunction)
+∞
6.3
6
*
Q87.17
ICD-10 Finland
Russel-Silver syndrome
+∞
6.3
6
*
Q87.00
ICD-10 Finland
Syndrome Treacher Collins
+∞
6.3
6
*
RT490
NOMESCO Finland
NA
7.1
6.2
14
20
FCA70
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft
26.9
6.2
8
*
NGK20
NOMESCO Finland
Epiphysiodesis of knee or lower leg
26.9
6.2
8
*
QBA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of trunk
26.9
6.2
8
*
I72.8
ICD-10 Finland
Aneurysm and dissection of other specified arteries
26.9
6.2
8
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.1
6.2
32
107
J01DB01
ATC
cefalexin; oral
1.6
6.2
517
4518
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
3.2
6.2
30
96
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.2
6.2
30
96
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
6.4
6.2
15
24
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
3.5
6.2
27
80
Q23.11
ICD-10 Finland
Bicuspid aortic valve
5.8
6.2
16
28
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
7.8
6.1
13
17
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.1
170
1158
JDB00
NOMESCO Finland
Gastrostomy
12.6
6.1
10
8
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.1
6.1
69
352
H61.2
ICD-10 Finland
Impacted cerumen
2.7
6.1
40
156
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
6.1
52
233
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
8.7
6.1
12
14
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
10.1
6.0
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
248
911
3.55
54.39
4.8
4.0
ng/l
1203.5
850.2
0.78
218
734
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
118
289
4.65
45.19
3.5
4.8
ng/l
151.3
166.8
0.19
111
259
(3032080) INR in Blood by Coagulation assay
325
1637
2.72
38.50
17.1
6.3
inr
1.5
1.1
4.17
80
498
(3003458) Phosphate [Moles/volume] in Serum or Plasma
212
905
2.86
33.96
11.0
9.9
mmol/l
1.2
1.2
0.48
206
865
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
404
2388
2.47
32.74
15.9
9.7
mmol/l
1.2
1.2
3.17
383
2238
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
65
128
5.46
31.87
7.3
20.4
u/ml
0.3
0.3
0.68
37
78
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
424
2599
2.42
31.17
14.4
9.5
mmol/l
1.2
1.2
2.48
375
2312
(3023368) Bacteria identified in Blood by Culture
241
1177
2.53
28.89
6.0
4.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
184
804
2.70
27.57
3.8
2.8
umol/l
12.3
14.3
3.35
177
753
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
162
675
2.78
26.54
4.0
2.9
%
21.2
24.1
2.15
149
601
(3004789) Transferrin [Mass/volume] in Serum or Plasma
170
735
2.69
25.86
3.8
2.7
g/l
2.3
2.4
1.17
161
688
(3024561) Albumin [Mass/volume] in Serum or Plasma
344
2043
2.24
25.71
7.0
6.6
g/l
36.3
37.2
2.04
328
1928
(3018418) pH of Serum or Plasma
257
1362
2.34
25.12
7.1
4.0
ph
7.4
7.4
0.41
50
238
(3000991) Gas panel - Venous blood
164
736
2.56
22.90
12.5
10.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
102
364
3.08
21.95
48.8
15.0
inr
1.6
1.2
0.83
11
65
(3044640) Blood type and Crossmatch panel - Blood
291
1716
2.12
21.14
3.5
2.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
362
2319
2.07
21.03
3.6
2.9
nmol/l
75.4
71.9
1.69
339
2162
(3012095) Magnesium [Moles/volume] in Serum or Plasma
175
844
2.39
20.72
7.7
8.1
mmol/l
0.8
0.8
0.03
169
804
(3042936) Bacteria identified in Isolate by Culture
155
712
2.48
20.41
2.4
2.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
355
2282
2.04
20.18
7.7
8.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
250
1416
2.14
19.96
2.7
2.7
mg/l
3.1
2.8
1.01
223
1249
(3002582) Erythrocytes [#/volume] in Urine
281
1666
2.09
19.87
5.2
3.6
e6/l
422.7
43.4
0.47
222
1262
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
174
853
2.35
19.77
3.7
3.5
ng/l
1406.4
656.4
0.70
126
522
(3022096) Basophils/100 leukocytes in Blood
437
3047
2.02
19.53
7.9
7.8
%
0.6
0.7
0.39
417
2896
(3036489) Thrombin time
90
322
3.03
19.21
4.3
6.9
s
21.9
22.8
0.87
85
301
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
60
166
3.84
19.18
1.7
2.2
g/l
1.2
1.3
0.30
48
149
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
91
328
3.01
19.17
5.7
10.8
%
90.8
91.6
0.13
91
323
(3027945) Reticulocytes/100 erythrocytes in Blood
139
626
2.49
19.01
4.1
5.8
%
1.7
1.6
0.47
133
582
(3013826) Glucose [Moles/volume] in Serum or Plasma
446
3160
1.99
18.72
10.3
5.9
mmol/l
6.2
6.4
1.58
426
2918
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
303
1886
2.01
18.42
5.5
3.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
442
3138
1.97
18.26
8.0
7.7
%
3.1
3.0
0.82
423
2975
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
378
2548
1.96
18.16
7.5
7.1
umol/l
15.6
15.1
0.12
359
2406
(3001604) Monocytes [#/volume] in Blood
458
3302
1.97
17.96
8.0
7.6
e9/l
0.6
0.6
1.12
401
2826
(3003396) Base excess in Arterial blood by calculation
109
448
2.67
17.95
14.9
9.7
mmol/l
0.2
0.9
0.68
94
359
(3006315) Basophils [#/volume] in Blood
458
3309
1.96
17.77
8.0
7.6
e9/l
0.0
0.0
0.55
401
2829
(3019069) Monocytes/100 leukocytes in Blood
442
3161
1.95
17.61
8.2
8.0
%
8.9
8.3
4.36
423
3015
(3018095) Leukocytes [#/volume] in Urine
315
2014
1.96
17.51
6.1
4.1
e6/l
160.5
41.0
0.61
232
1342
(3012544) pH of Venous blood
161
802
2.28
17.42
8.6
9.3
—
7.3
—
0
6
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
211
1184
2.08
16.83
2.8
3.2
mg/l
2.2
1.0
2.08
159
874
(3013115) Eosinophils [#/volume] in Blood
465
3412
1.93
16.82
8.7
8.3
e9/l
0.2
0.2
0.28
411
2973
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
526
4026
1.99
16.74
8.9
6.7
u/l
92.6
91.0
0.21
502
3804
(3002032) Base excess in Venous blood by calculation
157
790
2.24
16.51
8.6
9.3
mmol/l
1.8
1.3
0.87
139
633
(3019198) Lymphocytes [#/volume] in Blood
465
3426
1.91
16.45
8.0
7.6
e9/l
1.9
2.1
5.33
412
3002
(40758558) Short blood count panel - Blood
279
1742
1.95
16.38
9.5
8.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
254
1538
1.98
16.30
5.1
3.5
e6/l
0.3
0.3
0.11
203
1143
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
233
1372
2.00
16.18
3.0
2.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
76
272
2.99
16.17
2.2
2.4
ug/l
13.6
7.9
1.22
71
244
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
69
235
3.13
15.98
16.0
12.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
448
3289
1.88
15.71
8.0
7.6
%
29.1
32.0
5.99
428
3138
(3000850) Epithelial cells [#/volume] in Urine
198
1112
2.05
15.61
4.4
2.9
e6/l
6.0
6.8
0.33
179
976
(3019550) Sodium [Moles/volume] in Serum or Plasma
685
5869
2.65
15.40
24.9
12.4
mmol/l
139.4
139.6
1.51
671
5722
(3023103) Potassium [Moles/volume] in Serum or Plasma
685
5879
2.63
15.16
25.2
12.5
mmol/l
4.0
3.9
3.81
670
5711
(36304419) Bacteria [Presence] in Urine
251
1546
1.93
15.11
4.8
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
449
3343
1.83
14.59
4.2
2.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
88
362
2.62
14.38
10.0
17.3
mg/l
1.4
1.1
1.69
83
353
(3026008) Bacteria identified in Urine by Culture
223
1343
1.93
14.22
3.5
2.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
437
3248
1.81
14.06
7.8
7.5
%
55.3
53.3
2.69
416
3099
(3013650) Neutrophils [#/volume] in Blood by Automated count
483
3703
1.83
13.98
11.6
10.2
e9/l
3.8
3.8
0.16
424
3168
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
84
344
2.62
13.84
3.1
2.7
ml/min/173m2
71.3
77.3
0.49
34
139
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
129
643
2.21
13.72
7.9
9.3
mmol/l
24.0
23.7
0.72
123
616
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
359
2553
1.77
13.10
4.9
4.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
213
1295
1.89
13.03
2.6
2.2
u/l
323.1
285.7
0.20
205
1241
(3026782) Osmolality of Urine
183
1065
1.94
12.74
4.8
3.0
mosm/kgh2o
554.7
583.0
0.78
164
917
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
166
937
1.99
12.62
3.7
3.1
e6/l
0.8
0.8
0.11
102
528
(3023520) Reticulocytes [#/volume] in Blood
97
444
2.36
12.58
2.6
4.7
e9/l
82.7
69.2
1.60
63
306
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
16
19
8.58
12.40
1.5
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
161
906
1.98
12.32
4.0
3.3
e6/l
2.8
2.6
0.16
98
497
(3021589) Normoblasts [#/volume] in Blood
403
2996
1.73
12.30
11.6
10.0
e9/l
0.0
0.0
0.51
327
2365
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
253
1659
1.78
11.95
2.0
1.7
pmol/l
96.9
96.0
0.10
132
876
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
14
15
9.48
11.68
1.2
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
134
721
2.04
11.58
2.5
1.9
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
37
104
3.69
11.57
3.8
4.0
%
13.0
9.9
1.00
29
89
(3007853) Bacteria identified in Skin by Aerobe culture
135
732
2.02
11.41
2.3
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
40
120
3.46
11.36
4.0
3.8
e9/l
1.4
1.3
0.03
32
75
(3009343) pH of Capillary blood
132
713
2.03
11.27
12.5
9.2
ph
7.4
7.4
—
9
33
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
132
716
2.02
11.13
12.5
9.2
kpa
5.3
5.1
2.22
127
683
(3024928) Oxygen saturation in Venous blood
42
133
3.28
10.97
10.8
11.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
130
706
2.01
10.91
12.5
9.3
mmol/l
1.6
1.1
1.06
103
521
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
35
101
3.58
10.54
4.0
4.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
281
1954
1.69
10.49
3.5
4.0
u/l
35.1
31.0
0.55
273
1868
(3015377) Calcium [Moles/volume] in Serum or Plasma
238
1585
1.73
10.39
4.2
3.1
mmol/l
2.4
2.4
0.97
217
1431
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
59
236
2.62
10.18
1.8
1.7
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
14
18
7.90
10.16
1.8
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
156
924
1.86
10.08
1.8
1.4
nmol/l
20.2
19.9
0.09
140
809
(3031040) Bacteria [#/volume] in Urine by Automated count
451
3567
1.65
10.00
5.7
3.8
e6/l
489.7
512.5
0.02
15
37
(3019309) Folate [Moles/volume] in Red Blood Cells
112
594
2.04
10.00
1.8
1.6
nmol/l
1095.7
1173.3
0.42
91
473
(3022313) Gas panel - Capillary blood
114
609
2.02
9.98
11.4
9.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
550
4634
1.67
8.98
4.6
3.8
pmol/l
14.7
14.4
1.87
524
4294
(3003181) Sodium [Moles/volume] in Urine
30
91
3.39
8.41
4.1
3.1
mmol/l
83.1
75.1
0.28
24
82
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
98
535
1.95
8.02
2.5
2.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
34
115
3.05
8.01
2.8
2.8
g/l
134.0
131.6
0.21
26
90
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
12
17
7.15
8.01
1.8
1.8
mg/l
2.2
1.3
0.41
12
12
(3023323) Follitropin [Units/volume] in Serum or Plasma
88
463
2.02
8.00
2.0
1.8
iu/l
17.3
17.8
0.04
67
365
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
84
3.42
7.99
7.8
5.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
375
2934
1.55
7.96
4.0
3.1
ug/l
122.7
86.4
1.10
351
2766
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
96
525
1.95
7.82
2.5
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
214
1479
1.62
7.75
4.1
2.9
ng/l
27.6
43.7
0.68
138
775
(3035637) Corticotropin [Mass/volume] in Plasma
41
158
2.68
7.64
1.6
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
37
135
2.83
7.64
1.8
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
704
6463
2.17
7.62
18.8
9.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
558
4807
1.60
7.43
18.8
8.9
ml/min/173m2
95.8
94.3
0.61
457
3705
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
30
99
3.11
7.38
3.3
3.1
e6/l
622.2
792.5
—
6
22
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
81
426
2.01
7.37
4.3
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
106
614
1.84
7.24
1.6
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
67
332
2.12
7.15
2.0
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
466
3878
1.52
7.06
5.8
4.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
14
28
5.07
6.72
2.2
3.6
ug/l
144.2
171.0
0.17
14
28
(3030981) Hyaline casts [#/volume] in Urine by Automated count
51
232
2.28
6.72
4.0
3.2
e6/l
0.1
0.1
0.26
46
223
(3017446) Testosterone [Moles/volume] in Serum or Plasma
91
514
1.87
6.72
2.6
2.2
nmol/l
11.5
12.7
0.65
78
455
(1616796) Gas panel - Central venous blood
28
95
3.02
6.59
6.6
5.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
607
5401
1.61
6.39
5.3
4.3
mu/l
1.9
2.1
0.25
581
5075
(3013512) EKG study
159
1066
1.62
6.38
3.9
3.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
43
186
2.39
6.35
1.4
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
675
6189
1.79
6.15
21.8
11.4
mg/l
27.2
21.2
4.21
551
4549
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
27
95
2.91
5.99
1.5
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
27
95
2.91
5.99
3.1
2.9
%
17.7
16.7
0.83
17
49
(21494814) CD8 cells/100 lymphocytes in Specimen
10
16
6.32
5.96
2.8
2.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
57
287
2.06
5.86
1.8
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
97
2.85
5.78
6.0
5.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
17
5.94
5.63
1.0
2.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
47
224
2.17
5.57
10.1
6.7
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
16
42
3.87
5.55
1.4
1.0
%
92.8
89.1
—
8
23
(3002385) Erythrocyte distribution width [Ratio]
625
5655
1.58
5.53
26.0
14.8
%
13.7
13.3
5.98
615
5575
(3009508) Creatinine [Moles/volume] in Urine
211
1562
1.48
5.33
5.0
3.7
mmol/l
7.3
8.5
3.24
196
1382
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
109
697
1.66
5.24
4.7
5.4
umol/l
6.5
7.1
0.19
85
591
(3027315) Oxygen [Partial pressure] in Blood
26
97
2.74
5.21
6.1
5.2
kpa
9.0
8.9
0.13
26
97
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
262
0.22
5.16
1.5
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
93
573
1.71
5.14
4.0
3.2
g/l
9.7
9.5
0.20
84
531
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
8
6
13.45
5.08
1.1
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
54
282
1.98
5.05
1.6
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
68
384
1.85
5.04
2.4
1.9
u/l
5.8
7.5
1.10
42
291
(3005033) Fetal Nuchal fold Thickness US
6
256
0.23
5.01
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
258
0.23
5.00
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
156
1099
1.53
4.97
5.8
4.2
mg/mmol
14.9
24.6
0.28
117
749
(3029937) Albumin [Presence] in Urine by Test strip
190
1396
1.48
4.94
5.4
3.4
estimate
0.0
0.0
0.41
65
516
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
41
3.71
4.94
1.7
1.1
%
76.6
88.5
—
7
22
(3044941) Cell count panel - Synovial fluid
18
56
3.27
4.91
1.8
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
58
315
1.91
4.85
6.4
4.9
mmol/l
1.2
1.2
0.37
53
278
(3047181) Lactate [Moles/volume] in Blood
30
125
2.46
4.85
7.5
9.5
mmol/l
1.3
1.2
0.61
30
109
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
183
2.19
4.83
1.6
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
138
2.38
4.81
3.8
3.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
204
1528
1.46
4.79
2.7
2.8
u/l
55.5
55.3
0.01
189
1429
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
120
2.47
4.76
2.3
2.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
25
97
2.63
4.67
6.0
5.6
mmol/l
2.2
2.4
0.22
17
58
(3013290) Carbon dioxide [Partial pressure] in Blood
25
97
2.63
4.67
6.0
5.6
kpa
5.1
5.0
0.84
25
97
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
14
38
3.73
4.66
1.1
1.9
nmol/l
2.2
3.8
0.95
14
38
(3010375) cycloSPORINE [Mass/volume] in Blood
18
58
3.15
4.66
29.4
38.3
ug/l
100.1
149.9
2.00
13
53
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
118
794
1.57
4.60
1.6
1.6
pmol/l
430.4
21277036.7
0.80
96
705
(3011648) Oxygen content in Venous blood
21
75
2.85
4.58
16.9
16.2
%
11.0
11.7
0.40
21
75
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
32
143
2.29
4.46
2.0
1.7
—
—
—
0
0
(4062490)
22
82
2.73
4.44
1.3
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
23
88
2.66
4.43
1.6
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
148
1057
1.50
4.39
5.1
3.5
mg/l
96.6
368.9
1.37
114
735
(3005322) IgE [Units/volume] in Serum or Plasma
83
518
1.67
4.38
1.4
1.3
u/ml
238.6
251.1
0.05
77
477
(3015736) pH of Urine
271
2166
1.39
4.36
4.5
3.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
152
2.22
4.30
2.2
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
652
0.48
4.19
1.4
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
37
181
2.10
4.16
2.1
2.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
329
2732
1.36
4.11
5.1
3.2
estimate
0.0
0.0
0.00
67
512
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
142
2.23
4.10
1.8
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
142
2.23
4.10
1.8
1.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
12
32
3.79
4.09
1.6
1.8
nmol/l
20.3
16.2
—
6
10
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
83
528
1.64
4.08
3.0
2.4
u/l
29.6
31.9
0.37
77
446
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
111
2.39
4.03
4.4
4.2
%
55.9
55.0
0.13
26
111
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
18
64
2.85
3.97
1.4
1.9
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
38
3.46
3.91
6.3
9.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
119
2.31
3.91
1.6
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
119
2.31
3.91
1.6
1.9
g/l
3.7
3.7
0.01
20
90
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
119
2.31
3.91
1.6
1.9
g/l
6.7
7.1
0.57
21
97
(3011397) Hemoglobin [Presence] in Urine by Test strip
176
1328
1.42
3.90
4.2
3.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
72
448
1.67
3.86
2.1
1.9
g/l
1.1
1.1
0.02
66
418
(3037121) Protein [Mass/volume] in Urine
47
258
1.87
3.85
4.1
6.3
g/l
0.3
0.3
0.24
28
172
(3000475) Leukocytes [#/volume] in Synovial fluid
21
83
2.57
3.82
1.8
1.6
e6/l
4387.7
16818.8
1.10
16
59
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
114
2.32
3.81
1.6
1.9
g/l
3.3
3.0
0.82
20
93
(3002256) Pathology report gross observation
89
592
1.57
3.65
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
59
355
1.72
3.59
4.2
3.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
111
2.29
3.58
3.7
3.9
e9/l
3.4
4.0
0.88
25
111
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
111
2.29
3.58
1.7
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
153
1146
1.42
3.51
3.4
3.1
umol/l
3073.1
5237.9
0.32
141
1041
(3042733) HLA Ab [Presence] in Serum
13
41
3.21
3.50
6.3
2.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
623
1.54
3.50
1.6
1.5
—
—
—
0
0
(44790048)
27
127
2.17
3.39
2.4
2.1
—
—
—
0
0
(44806118)
27
127
2.17
3.39
2.4
2.1
—
—
—
0
0
(44790049)
27
127
2.17
3.39
2.4
2.1
—
—
—
0
0
(44790047)
27
127
2.17
3.39
2.4
2.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
182
1.97
3.38
2.1
2.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
10
7.05
3.37
3.6
3.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
505
4544
1.33
3.36
5.4
4.4
mmol/mol
37.0
38.1
2.03
480
4322
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
668
6291
1.50
3.33
12.5
9.1
u/l
27.5
27.1
0.18
652
6111
(3021601) Nitrite [Presence] in Urine by Test strip
323
2736
1.31
3.32
7.0
4.6
estimate
0.0
0.0
0.50
68
531
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
459
0.46
3.28
1.4
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
311
1.72
3.25
3.5
4.3
ug/l
4.5
20.1
0.57
33
248
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
33
598
0.53
3.23
1.6
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
45
259
1.78
3.21
1.5
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
325
2768
1.30
3.17
5.1
3.3
estimate
0.0
0.0
0.00
65
506
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
44
2.99
3.14
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
99
2.26
3.08
2.1
2.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
98
692
1.48
3.07
2.4
2.5
mmol/l
2.4
2.4
0.16
85
588
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
29
3.48
3.05
3.5
8.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
30
3.36
2.91
3.5
8.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
734
7101
1.90
2.90
30.6
16.7
e9/l
255.5
260.4
1.06
725
6884
(3013707) Erythrocyte sedimentation rate by Westergren method
465
4179
1.29
2.89
4.6
4.0
mm/h
10.8
8.9
2.24
436
3902
(40768446) Kidney Pathology biopsy report
13
47
2.80
2.82
2.0
2.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
734
7107
1.88
2.80
30.5
16.6
fl
89.1
88.8
0.79
729
7028
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
84
2.29
2.79
1.7
1.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
734
7108
1.87
2.78
30.4
16.6
pg
29.7
29.8
0.88
729
7029
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
138
1.99
2.78
1.3
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
31
3.25
2.78
1.6
3.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
734
7109
1.87
2.76
30.6
16.7
e12/l
4.5
4.6
5.55
722
6874
(3010813) Leukocytes [#/volume] in Blood
734
7112
1.86
2.71
30.7
16.7
e9/l
6.8
6.7
0.43
723
6878
(3023419) Bacteria identified in Sputum by Culture
11
37
3.00
2.70
6.8
5.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
734
7113
1.85
2.69
31.1
16.9
g/l
132.4
136.5
10.40
729
7033
(3052851) Hemolysis interference index of Serum or Plasma
33
183
1.84
2.69
3.1
3.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
24
3.78
2.67
1.1
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
61
2.49
2.63
1.3
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
54
813
0.64
2.62
1.1
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
237
1980
1.28
2.57
1.5
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
13
50
2.63
2.54
2.5
2.7
%
36.5
41.0
—
6
14
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
33
3.06
2.53
1.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
322
0.45
2.47
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
322
0.45
2.47
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
335
0.47
2.46
2.3
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
348
0.48
2.46
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
321
0.46
2.45
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
320
0.46
2.43
1.5
1.4
—
—
—
0
0
(3020891) Body temperature
29
160
1.84
2.42
20.7
6.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
34
2.97
2.41
1.0
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
166
1336
1.31
2.38
1.6
1.8
mmol/l
1.6
1.4
1.92
150
1184
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
155
1.84
2.32
1.4
1.4
ug/g
364.5
323.5
0.62
21
80
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
239
1.66
2.30
2.3
1.9
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
13
4.64
2.27
2.7
2.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
15
66
2.30
2.25
1.0
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
323
0.48
2.24
1.2
1.3
miu/ml
139.2
256.3
—
8
163
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
38
233
1.66
2.24
2.4
1.9
u/ml
113.7
97.8
—
5
28
(3051593) INR in Capillary blood by Coagulation assay
5
9
5.58
2.21
6.4
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
22
397
0.54
2.19
2.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
19
3.71
2.15
1.1
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
19
3.71
2.15
1.0
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
130
1.87
2.14
1.2
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
102
1.99
2.11
1.3
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
37
2.72
2.10
3.4
3.0
u/ml
580.1
705.3
—
10
37
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
117
1.91
2.07
2.1
1.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
10
5.02
2.07
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
21
111
1.92
2.02
2.5
2.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
44
2.52
2.01
1.6
3.1
nmol/l
2.0
6.7
0.70
11
44
(40760888) Immunoglobulin light chains.free panel - Serum
13
57
2.30
1.98
1.4
3.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
65
465
1.43
1.96
6.8
3.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
50
717
0.68
1.95
1.9
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
104
1320
0.75
1.94
1.9
1.7
—
—
—
0
0
(4035726)
56
392
1.46
1.90
1.4
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
22
3.20
1.88
1.3
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
56
393
1.46
1.87
1.9
1.6
mu/l
382.3
300.5
0.93
50
358
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
46
2.41
1.85
2.0
2.4
pg
33.5
32.6
0.47
11
46
(3027944) Amphetamines [Presence] in Urine
39
581
0.65
1.85
1.5
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
115
1.85
1.84
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
17
3.55
1.84
2.2
3.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
66
888
0.72
1.81
2.0
2.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
53
2.28
1.81
1.1
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
533
4991
1.22
1.80
4.1
3.3
mmol/l
5.7
5.7
0.21
503
4638
(40761535) Cells panel - Urine sediment
48
330
1.48
1.79
4.8
3.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
29
456
0.62
1.76
2.8
2.2
—
15.8
—
0
30
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
132
1.76
1.75
1.9
2.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
30
2.68
1.72
1.0
1.1
miu/ml
1303.1
1221.6
—
8
30
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
13
3.86
1.71
1.0
1.1
u/l
14.6
15.8
—
5
13
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
13
3.86
1.71
1.0
2.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
13
3.86
1.71
5.0
15.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
48
2.31
1.71
4.1
5.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
48
2.31
1.71
1.6
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
48
2.31
1.71
4.1
5.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
83
1.95
1.65
1.4
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
69
2.05
1.65
1.7
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
229
1993
1.21
1.64
2.1
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
176
2055
0.81
1.64
2.5
2.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
41
588
0.68
1.63
1.8
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
84
1.92
1.60
2.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
63
2.08
1.60
1.1
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
77
1.97
1.60
1.7
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
85
660
1.32
1.59
1.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
41
585
0.68
1.59
1.8
2.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
26
2.71
1.58
1.1
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
235
2057
1.21
1.58
5.3
3.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
23
137
1.70
1.56
2.4
3.1
u/ml
284.3
114.3
0.40
18
118
(3019150) Specific gravity of Urine by Refractometry
147
1228
1.24
1.56
4.9
3.2
kg/l
1.0
1.0
1.04
31
184
(3000764) Benzodiazepines [Presence] in Urine
41
582
0.69
1.55
1.8
2.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
7
27
2.61
1.51
2.4
3.1
umol/l
1.1
1.1
—
7
27
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
27
2.61
1.51
3.1
2.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
56
411
1.39
1.51
5.3
5.2
%
0.3
0.1
0.48
16
118
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
112
1362
0.79
1.50
2.3
2.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
124
1488
0.80
1.48
2.3
2.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
32
211
1.54
1.48
2.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
45
2.24
1.46
1.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
45
2.24
1.46
1.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
45
2.24
1.46
1.3
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
18
102
1.78
1.45
1.3
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
52
2.13
1.44
1.3
1.4
nmol/l
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
16
3.14
1.44
2.0
3.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
16
3.14
1.44
1.2
1.2
pmol/l
348.6
351.4
—
5
11
(3008536) Aspergillus sp Ab [Presence] in Serum
5
16
3.14
1.44
2.6
2.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
59
2.05
1.44
1.6
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
23
2.62
1.37
3.7
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
14
75
1.88
1.35
4.4
4.1
umol/l
23.9
25.2
0.22
14
75
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
54
2.05
1.33
6.2
3.9
ug/l
20.6
26.1
0.62
11
54
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
17
281
0.60
1.31
1.6
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
53
396
1.36
1.31
5.4
5.3
%
0.0
0.1
0.73
13
100
(3044927) Protein electrophoresis panel - Urine
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
27
177
1.54
1.30
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
106
1.71
1.30
1.6
1.2
u/ml
3.9
4.1
0.04
12
50
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
106
1.71
1.30
1.3
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
40
550
0.71
1.30
1.9
2.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
18
2.79
1.28
3.2
2.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
35
2.30
1.27
2.0
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
41
295
1.41
1.27
2.7
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
69
540
1.30
1.26
1.3
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
8
36
2.23
1.24
2.5
1.9
—
16.5
—
0
12
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
24
155
1.57
1.24
1.3
1.5
nmol/l
0.5
0.4
0.14
19
127
(21494434) Karyotype in Bone marrow
9
45
2.01
1.23
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
108
1.68
1.23
1.7
1.3
u/ml
1.4
5.1
—
8
42
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
108
1.68
1.23
2.1
2.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
645
6235
1.22
1.20
24.6
13.2
%
39.3
40.3
3.54
528
5256
(3025941) Bacteria identified in Stool by Culture
48
359
1.36
1.19
1.2
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
6
26
2.32
1.19
4.2
2.5
min
512.7
516.8
—
6
15
(3017181) Myelocytes/100 leukocytes in Blood
57
439
1.32
1.18
5.2
5.1
%
2.2
0.7
1.04
18
133
(3007164) IgA [Mass/volume] in Serum or Plasma
206
1827
1.17
1.17
1.7
1.6
g/l
2.0
2.0
0.13
111
1042
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
20
2.51
1.15
1.6
2.9
umol/l
24.2
36.6
—
5
13
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
20
2.51
1.15
1.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
20
2.51
1.15
1.2
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
20
2.51
1.15
3.0
1.8
ml
1614.8
2093.3
—
5
20
(3045424) Erythrocytes [Presence] in Urine
14
80
1.76
1.13
2.1
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
58
1.91
1.12
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
104
1.65
1.10
1.4
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
12
66
1.83
1.09
3.6
4.0
mmol/l
5.5
7.2
4.50
12
66
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.4
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.4
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.4
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
41
1.96
1.09
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
524
4995
1.16
1.07
3.9
3.2
mmol/l
1.3
1.2
2.04
500
4716
(3004616) Nuclear Ab [Presence] in Serum
11
59
1.88
1.07
1.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
59
1.88
1.07
2.3
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
53
411
1.31
1.06
4.2
2.5
e9/l
4.1
4.0
0.16
48
358
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
58
457
1.29
1.04
7.0
5.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
46
1.97
1.03
1.3
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
22
2.28
1.03
1.2
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
22
2.28
1.03
1.2
1.3
—
—
—
0
0
(4268621)
13
75
1.75
1.03
3.0
2.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
95
1126
0.82
1.03
1.9
1.8
—
—
—
0
0
(4306422)
15
91
1.66
1.01
1.5
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
35
2.01
1.00
2.9
3.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
248
0.64
0.99
2.0
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
192
2133
0.87
0.97
1.8
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
23
157
1.48
0.97
1.3
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
547
5250
1.15
0.95
4.4
3.8
mmol/l
2.8
2.8
0.62
522
4946
(3002179) Metamyelocytes/100 leukocytes in Blood
51
401
1.29
0.94
4.5
4.9
%
1.2
0.4
—
10
93
(3011985) Renin [Units/volume] in Plasma
11
62
1.78
0.94
1.3
1.4
mu/l
25.4
226.0
0.70
11
54
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
62
1.78
0.94
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
172
1530
1.16
0.94
5.2
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
116
999
1.19
0.94
2.2
1.6
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
27
2.23
0.93
1.7
1.2
—
—
—
0
0
(4024509)
6
27
2.23
0.93
2.7
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
544
5222
1.14
0.93
4.2
3.6
mmol/l
4.5
4.6
2.93
522
4962
(1001926) Buprenorphine [Presence] in Urine by Screen method
35
462
0.75
0.93
2.0
2.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
58
467
1.26
0.90
3.4
2.4
u/l
11430.1
3910.4
0.66
20
174
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
29
2.08
0.89
1.3
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
29
2.08
0.89
1.0
1.3
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
29
2.08
0.89
3.8
7.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
29
2.08
0.89
3.5
7.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
12
71
1.70
0.89
1.6
2.1
—
—
—
0
0
(4281824)
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
30
2.01
0.87
4.0
2.5
ml
720.0
652.6
—
6
16
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
44
1.83
0.86
1.3
1.2
nmol/l
2.1
1.4
—
8
38
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
44
1.83
0.86
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
539
5183
1.13
0.85
4.1
3.5
mmol/l
1.3
1.4
11.00
515
4898
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
31
1.94
0.84
1.7
4.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
65
1.70
0.82
3.9
4.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
14
89
1.58
0.81
1.0
1.0
g/l
1.5
1.4
0.45
14
81
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
59
483
1.24
0.81
3.2
3.3
%
31.4
31.3
0.04
46
350
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
36
277
1.31
0.80
1.9
1.8
u/ml
279.6
206.6
0.53
22
143
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
10
58
1.73
0.79
1.3
1.4
pmol/l
273.6
541.3
—
10
49
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
48
1.67
0.79
1.5
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
48
1.67
0.79
1.5
1.2
%
69.8
77.7
—
8
48
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
12.9
—
0
16
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
2.8
—
0
16
(3014765) Yersinia sp identified in Stool by Organism specific culture
28
209
1.35
0.76
1.3
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
63
524
1.22
0.76
1.4
1.3
iu/ml
179.8
157.6
0.11
18
203
(3037756) Immunofixation for Serum or Plasma
9
54
1.67
0.74
1.4
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
108
1.49
0.74
2.0
1.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
36
281
1.29
0.73
1.9
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
38
1.85
0.73
5.3
2.9
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
38
1.85
0.73
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
38
1.85
0.73
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
530
5475
0.89
0.73
3.7
3.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
106
0.56
0.73
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
159
1.39
0.73
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
39
1.80
0.72
1.3
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
10
60
1.67
0.72
3.5
2.3
umol/l
13.8
16.2
—
10
60
(3051611) Lipemic interference index of Serum or Plasma
12
76
1.59
0.72
4.3
4.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
420
4007
1.11
0.70
3.7
3.6
u/l
49.4
37.5
2.16
399
3851
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
30
230
1.32
0.70
1.8
1.6
nmol/l
40.6
37.8
0.19
30
224
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
142
0.63
0.70
1.3
1.6
—
—
—
0
0
(44813793)
9
58
1.56
0.70
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
61
1.65
0.68
1.5
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
144
1.40
0.68
1.4
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
170
1.36
0.68
2.5
1.9
iu/l
4.2
5.2
—
10
59
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
11
167
0.65
0.66
1.5
2.1
nmol/l
0.7
0.6
0.11
11
142
(21494890) Protein electrophoresis panel - 24 hour Urine
5
28
1.79
0.66
1.2
3.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
28
215
1.31
0.65
1.3
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
120
1.43
0.65
1.1
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
97
853
1.16
0.65
1.5
1.4
titre
517.8
483.2
0.04
18
162
(1002224) Polysomnography panel
33
261
1.28
0.63
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
155
1411
1.12
0.62
5.3
4.9
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
71
1.56
0.62
1.5
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
14
96
1.47
0.61
1.1
1.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
21
156
1.36
0.61
1.8
1.7
pmol/l
171.8
222.1
1.02
21
149
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
19
255
0.74
0.61
1.5
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
214
1986
1.11
0.61
1.5
1.6
u/ml
4.3
2.3
0.43
58
453
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
80
1.51
0.60
1.0
1.6
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
15.1
—
0
14
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
1.4
—
0
12
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
53
1.51
0.58
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
112
0.62
0.58
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
35
1.72
0.57
1.3
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
36
1.67
0.56
1.2
1.2
—
65.0
—
0
6
(3028433) Virus identified in Specimen by Culture
6
36
1.67
0.56
1.0
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
24
185
1.31
0.56
1.4
3.5
mg/l
325.9
457.3
1.51
24
180
(36660697) Celiac disease serology panel - Serum
89
788
1.15
0.56
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
382
0.80
0.54
1.7
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
222
1.27
0.54
2.0
2.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
31
250
1.25
0.53
1.5
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
66
1.52
0.52
1.3
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
79
891
0.87
0.52
1.4
1.2
u/ml
11.0
6.8
0.23
35
352
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
63
1.43
0.52
1.6
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
180
0.72
0.52
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.6
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.6
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
64
1.41
0.51
1.6
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
28
346
0.80
0.51
1.1
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
41
1.47
0.50
8.7
5.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
41
1.47
0.50
1.3
1.2
iu/ml
356.2
182.3
—
6
41
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
41
1.47
0.50
1.2
1.7
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
41
1.47
0.50
4.3
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
41
1.47
0.50
4.2
3.1
mmol/l
4.0
4.0
—
6
41
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
41
1.47
0.50
4.2
3.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
41
1.47
0.50
4.2
3.1
mmol/l
101.5
105.1
—
6
41
(3003740) Influenza virus B Ag [Presence] in Specimen
25
198
1.27
0.50
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
207
1.26
0.50
1.2
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
46
1.53
0.48
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
25
199
1.26
0.48
1.3
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
165
0.72
0.47
1.2
1.1
—
—
—
0
0
(4010399)
40
338
1.19
0.46
2.1
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
49
1.43
0.46
1.4
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
275
0.79
0.45
2.3
2.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
87
1.38
0.42
1.8
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
33
1.52
0.41
1.0
1.2
%
124.2
111.5
—
5
28
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
5
34
1.47
0.40
2.0
2.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
1.2
1.6
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
61
1.31
0.39
1.0
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
97
1.35
0.39
2.2
4.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
105
0.66
0.39
1.7
1.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.7
g/l
1.0
1.0
—
5
35
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
66
1.37
0.38
1.1
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
4.0
3.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
111
0.72
0.37
1.4
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
116
1.30
0.37
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
43
1.40
0.35
1.5
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
15
188
0.79
0.33
1.1
1.1
u/ml
4.2
0.3
—
6
74
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
132
0.75
0.32
1.1
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
47
1.28
0.32
2.7
2.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
47
1.28
0.32
1.0
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
352
1.14
0.31
1.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
54
1.30
0.30
1.3
2.1
—
—
—
0
0
(3000492) Spirometry study
65
593
1.10
0.29
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
177
1855
0.94
0.29
2.4
2.1
—
—
—
0
0
(4027681)
7
57
1.23
0.29
1.6
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
204
1.18
0.28
5.5
2.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
216
0.83
0.28
1.4
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
85
1.30
0.28
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
85
1.30
0.28
9.0
3.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
186
1.19
0.28
1.2
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
64
1.25
0.27
1.6
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
77
1.30
0.26
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
82
878
0.93
0.25
2.4
1.8
%
1.6
1.4
0.67
77
812
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
20
170
1.18
0.24
1.5
3.6
mmol/l
3.4
3.5
0.28
20
163
(3003327) Ova and parasites identified in Stool by Light microscopy
27
307
0.87
0.24
1.6
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
117
1107
1.07
0.24
2.5
3.0
ug/g
163.5
98.5
0.47
98
888
(3035933) Granulocytes/100 leukocytes in Blood
6
85
0.70
0.24
1.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
190
1.16
0.23
1.5
2.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
39
1.28
0.23
2.0
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
0.4
—
0
5
(4094501)
8
101
0.79
0.21
1.0
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
303
0.89
0.21
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
51
1.18
0.19
1.0
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
81
1.24
0.18
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
227
0.88
0.18
1.9
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
331
0.90
0.18
1.1
1.2
u/ml
2.9
2.8
0.03
20
192
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
33
362
0.91
0.18
1.6
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
119
1.18
0.17
1.8
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
60
562
1.07
0.17
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
63
1.11
0.17
1.1
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
106
1016
1.05
0.15
3.8
3.9
ug/l
1.9
1.7
0.22
98
916
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
79
1.14
0.15
2.0
1.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
79
1.14
0.15
1.0
1.1
—
—
—
0
0
(4034850)
19
170
1.12
0.13
15.1
9.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
37
394
0.94
0.11
5.3
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
149
1452
1.03
0.11
2.1
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
90
929
0.96
0.10
1.4
1.2
iu/ml
32.4
24.8
0.14
29
265
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
45
1.11
0.10
1.2
1.3
mmol/l
1.6
1.8
—
5
45
(3011841) English Walnut IgE Ab [Units/volume] in Serum
5
46
1.09
0.09
1.2
1.2
u/ml
0.9
10.6
—
5
41
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
5
46
1.09
0.09
1.2
1.2
u/ml
13.6
5.3
—
5
40
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
206
0.92
0.09
1.1
1.1
u/ml
4.6
6.7
—
9
107
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
6
58
1.03
0.08
1.0
1.0
g/l
181.5
166.8
—
6
58
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
58
1.03
0.08
1.0
1.0
—
—
—
0
0
(4198724)
6
71
0.84
0.07
2.0
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
85
0.82
0.07
1.1
4.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
28
295
0.95
0.06
1.1
1.2
u/ml
5.2
2.9
—
8
100
(3004716) Salmonella sp identified in Stool by Organism specific culture
44
456
0.96
0.06
1.4
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
78
796
0.98
0.04
3.6
3.6
%
25.3
21.5
0.70
26
300
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
63
643
0.98
0.04
1.6
1.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
56
571
0.98
0.03
2.3
2.5
ug/l
0.7
0.7
0.15
37
313
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
188
0.96
0.02
1.1
1.1
u/ml
5.8
7.5
0.18
11
103
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
103
1019
1.01
0.02
1.4
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
29
298
0.97
0.02
1.1
1.2
u/ml
1.3
1.1
0.09
17
196
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
287
0.97
0.01
1.4
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
103
0.97
0.00
1.2
5.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
152
0.99
0.00
1.0
1.9
—
—
—
0
0
(3006598) pH of Arterial cord blood
11
114
0.96
0.00
1.0
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
116
1.03
0.00
8.2
3.5
u/ml
79.8
4.3
0.59
12
107
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
105
0.95
0.00
1.3
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
30
304
0.99
0.00
1.1
1.2
u/ml
3.1
6.9
1.43
22
212
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
213
0.98
0.00
1.5
1.6
iu/ml
0.0
0.0
—
6
50
(3044290) Cell count panel - Cerebral spinal fluid
16
158
1.01
0.00
1.1
3.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
216
1.02
0.00
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
49
488
1.00
0.00
1.9
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
55
0.91
0.00
1.4
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
97
0.93
0.00
1.0
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
7
74
0.94
0.00
1.0
1.3
—
278.5
—
0
13
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.3
—
0
5
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
6.6
—
3.6
—
0
9
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
72
0.97
0.00
1.4
1.5
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
56
0.89
0.00
1.4
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
194.6
—
0
5
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
57
0.88
0.00
2.6
2.7
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Q17_CLEFT_PALATE_EXCLUDE – Exclusion endpoint for clefts

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).